About this trial
Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients who are in cardiac care units suffering from cardiovascular diseases prescribed with LMWH injections two times per day
Chinese
Disqualifiers
cognitively impaired
unconscious
refuse to participate
Trial design
Parallel
Treatments tested in this trial
Active Control
Other interventionPatients in the control group will receive the usual practice of subcutaneous LMWH injection administered by nurses.
Standardized injection protocol
Other interventionNurses administer LMWH according to the standardized evidence-based protocol.
Treatment groups
Trial outcomes
Primary outcomes
Bruise size
The bruising length and width will be measured by a ruler and the incidence of bruising will be recorded.
Pain level
Patients' pain levels are assessed using the Numeric Rating Scale: from o to 10, with "10" representatin the worst outcome and with '0' representing the best outcome.
Secondary outcomes
Patient Experience
a Patient Experience Surveys to evaluate their perceived nurse's attitude
Communicative Competence
Communicative Competence Scale consists of 36 items across five dimensions (General Competence, Empathy Affiliation/Support, Behavioural Flexibility, and Social Relaxation), using a 5-point Likert scales ranging from strongly agree to strongly disagree (coded from 1 to 5). Higher the score means worse the outcome.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.